Clinical trial
Phase II Trial of Metformin Combined to Irinotecan for Refractory Metastatic or Recurrent Colorectal Cancer
NCT01930864 is registered in ClinicalTrials.gov with Barretos Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Metformin Combined to Irinotecan for Refractory Metastatic or Recurrent Colorectal Cancer
- Lead sponsor
- Barretos Cancer Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 1, 2015
- Completion date
- December 1, 2020
- Enrollment
- 41 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.